Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.


Clinical Trial Description

Double-blinded phase II clinical study. We will compare the effect of calcium electroporation for the treatment of cutaneous metastases with standard treatment: electrochemotherapy with intratumoral injection of bleomycin. Separate randomisation will be performed and the lesions will be treated with either intratumoral injection of calcium or bleomycin. It is a once only treatment and the patients will be followed up for 6 months.

It is a non-inferiority study and we accept a difference in response on 15%. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01941901
Study type Interventional
Source Herlev Hospital
Contact
Status Completed
Phase Phase 2
Start date September 2013
Completion date January 23, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05481658 - Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases Phase 1